Craneware (LON:CRW – Get Free Report) had its price target dropped by research analysts at Berenberg Bank from GBX 2,900 to GBX 2,600 in a note issued to investors on Friday,London Stock Exchange reports. The brokerage currently has a “buy” rating on the stock. Berenberg Bank’s target price would suggest a potential upside of 115.39% from the company’s previous close.
Separately, UBS Group reissued a “buy” rating and issued a GBX 570 target price on shares of Craneware in a research note on Wednesday, March 25th. Four research analysts have rated the stock with a Buy rating, According to MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of GBX 2,222.75.
Get Our Latest Research Report on Craneware
Craneware Price Performance
Craneware Company Profile
For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster – that simplify the complexities of healthcare finance and operations.
Further Reading
- Five stocks we like better than Craneware
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for Craneware Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware and related companies with MarketBeat.com's FREE daily email newsletter.
